The FDA broadcast Endo's expanded recall of clonazepam tablets, used for panic disorder among other conditions, due to ...
Sixteen lots of clonazepam orally disintegrating tablets have been recalled because of a packaging error that could have life ...
Endo USA, Inc., affiliated to generics and specialty branded pharmaceutical company Endo, Inc., has expanded its recall of Clonazepam ...
The company is worried mislabeling could lead to unintentionally taking higher doses and adverse side effects.
The company that produces the tablets has said the medication is mislabeled with the incorrect strength on the carton.
Endo, Inc. issued a voluntary recall for Clonazepam tablets “due to potential product carton strength mislabeling.” In the Food and Drug Administration’s (FDA) recall alert posted on Nov ...
To date, Endo has not received any reports of adverse events associated with this product recall. Clonazepam Orally Disintegrating Tablets are indicated alone or as an adjunct in the treatment of ...